Navigation Links
Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
Date:6/9/2009

FREMONT, Calif., June 9 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Bruce A. Molitoris, M.D., Director, Division of Nephrology and Professor of Medicine, Indiana University, will present data demonstrating efficacy in models of acute and chronic kidney disease (AKI and CKD, respectively) of an animal analogue of QPI-1002 at the RNA Interference Summit being held June 8-10, 2009 in San Francisco, CA. QPI-1002, a siRNA drug candidate being developed by Quark Pharmaceuticals, Inc. is the first systemically-administered siRNA to enter human clinical trials. The drug is the subject of two multi-center Phase I studies for acute kidney injury (AKI) and one Phase I/II study for delayed graft function (DGF) in kidney transplantation. QPI-1002 targets p53, a gene that plays a pivotal role in the stress-response apoptotic pathway.

Using intravital 2-photon in life microscopy to follow the distribution of fluorescent labeled siRNA in the rat kidney, Prof. Molitoris demonstrated rapid and predominant distribution of the siRNA to kidney proximal tubular cells (PTC), which are the main type of suffering cells in the context of ischemic or toxic kidney injury. Dose response and time course studies exploring efficacy of the animal analogue of QPI-1002 in the AKI models in rats indicated excellent efficacy of the drug in reducing serum creatinine levels and ameliorating acute morphological damage to the kidney including PTC death. The data indicate that recurrent dosing of the drug concomitantly with monthly repetitive ischemic kidney insults minimizes the resulting kidney injury and can attenuate development of associated chronic kidney disease (CKD).

Daniel Zurr, Chief Executive Officer, commented, "We are excited to see this as a possible additional indication for QPI-1002; the compoun
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage
2. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
3. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
4. Keryx Biopharmaceuticals, Inc. Receives Extension for Nasdaq Listing Compliance
5. Raptor Pharmaceuticals to Collaborate with Roche on Therapeutic Delivery Across Blood-Brain Barrier
6. Metastorm Customer, Wyeth Pharmaceuticals, Wins CIO 100 Award for BPM Project
7. Endo Pharmaceuticals to Present at Goldman Sachs 30th Annual Healthcare Conference
8. Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference
9. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at the Needham Life Sciences Conference in New York on June 11, 2009
10. Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering
11. Isis Pharmaceuticals to Present at Goldman Sachs 30th Annual Global Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/28/2015)... 28, 2015 My Shiney Hiney® LLC., the ... team to Las Vegas, Nevada for the annual ASD Market ... of the leading consumer-goods tradeshows and My Shiney Hiney will ... event. My Shiney Hiney can be found at booth number ... for the at-home personal hygiene brush and cleansing system exclusively ...
(Date:2/27/2015)... A new study published in the Journal ... cycle on a regular basis and prostate cancer. While cycling ... the more hours per week a man spends cycling, the ... an increased importance on prostate cancer screening methods. , “This ... closely at patents’ risk factors for developing prostate cancer,” says ...
(Date:2/27/2015)... Clinovo, a leading provider of cloud-based eClinical ... (EDC) at the CALBIO2015 conference taking place ... 3rd at Booth # 141. , ClinCapture ... edit-check builder allowing Clinical Trials Managers to create CRFs ... any programming experience. Clinovo’s new pricing model offers a ...
(Date:2/27/2015)... 2015 In New York City, a ... providing free dental care from his Sheepshead Bay­neighborhood practice. ... Dentistry from the Heart, and will be hosting a ... 50 patients who are in need of fillings, extractions, ... have access to high­quality service of Dr. Umanoff's practice ...
(Date:2/27/2015)... 2015 Dr. Andrew Campbell, one of ... pleased to announce the expansion of Quintessa Aesthetic Center ... Quintessa has begun seeing patients on February 18, 2015. ... will offer a variety of state-of-the-art surgical and ... micro laser peels, chemical peels, microdermabrasion, ProFractional Laser, Broad ...
Breaking Medicine News(10 mins):Health News:My Shiney Hiney® to Participate in ASD Market Week 2015 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 2Health News:Study Finds That Cycling Increases Risk For Prostate Cancer 3Health News:Clinovo to Demo Its Self-Service, Cloud-Based EDC Solution at CALBIO2015 on March 2nd and 3rd, 2015 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 2Health News:Dr. Umanoff Unites with Dentistry from the Heart to Provide Community with Charitable Dental Care 3Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 2Health News:Dr. Andrew Campbell Expands Quintessa Aesthetic Center into Delafield 3
... yesterday in the lawsuit brought in Superior Court in ... during the,U.S. Medical Licensing Examination (USMLE). "Fairness to ... the,overriding concerns of the exam,s sponsors," said Joseph F. ... which co-sponsors the,exam and was named in the suit ...
... the September issue of the Journal of Periodontology (JOP) found ... plastic surgery than non-smokers. , The study followed 10 smokers ... of cigarette smoke on the long term outcomes of a ... of the teeth. After two years, residual gum recession ...
... symptoms may be mild, study finds , , TUESDAY, Sept. ... that tested positive for Gaucher disease, an inherited condition ... chose abortions, raising questions about the use of certain ... , The study authors also question the use of ...
... of Health (NIH) has awarded the University of Wisconsin-Madison,s new ... largest grants in the history of the UW School of ... an ambitious NIH plan to transform the country,s clinical and ... plan is to find ways to do a better job ...
... 3.0T Endorectal Coil for Prostate MR Now Available for All Three ... ... MEDRAD today announced the,availability of the 3.0T Prostate eCoil (TM) ... and Siemens. MEDRAD,introduced the 3.0T prostate eCoil for GE scanners in ...
... new grants will speed development of TB vaccines, diagnostic tests, ... drugs in support of the Global Plan ... & Melinda Gates,Foundation announced today grants totaling $280 million to ... earth and,kills nearly 2 million yearly - mostly in the ...
Cached Medicine News:Health News:Massachusetts State Court Hears Suit by Breastfeeding Mother on Medical Licensing Exam 2Health News:Study Questions Genetic Screening for Treatable Diseases 2Health News:Study Questions Genetic Screening for Treatable Diseases 3Health News:Major grant advances UW's clinical and translational research enterprise 2Health News:Major grant advances UW's clinical and translational research enterprise 3Health News:MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners 2Health News:MEDRAD Announces eCoil(TM) for Siemens, Philips 3.0T MR Scanners 3Health News:Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic 2Health News:Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic 3Health News:Gates Foundation Commits $280 Million for Research to Fight Global TB Epidemic 4
(Date:2/26/2015)... 2015  IRIDEX Corporation (NASDAQ: IRIX ) today ... year 2014 financial results after the market closes on ... the Company will host a conference call with the investment ... Thursday, March 5, 2015 to discuss the results of ... may access the live conference call via telephone by dialing ...
(Date:2/26/2015)... 26, 2015 Legislation passed today by the ... to help prevent inappropriate prescriptions in Medicare Part D ... Integrity of Medicare Act (PIMA) of 2014 , introduced ... Brady (R-TX) and Ranking Member Jim McDermott (D-WA), ... epidemic and implement the right policies, said the Pharmaceutical ...
(Date:2/26/2015)... , Feb. 26, 2015 Research and Markets ... the "Radiation Therapy Equipment - Global Strategic Business ... This report analyzes the worldwide markets for Radiation Therapy ... Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator. ... Canada , Japan ...
Breaking Medicine Technology:IRIDEX Announces Fourth Quarter and Full Year 2014 Conference Call and Release Date 2PCMA Statement on the 'Protecting the Integrity of Medicare Act' 2Radiation Therapy Equipment - Global Strategic Business Report 2015-2020: Linear Accelerator, Treatment Planning Systems, and Radiation Therapy Simulator 2
... , SOMERVILLE, N.J. , Jan. ... has completed the acquisition of Acclarent, Inc., following clearance ... privately held medical technology company dedicated to designing, developing ... nose and throat (ENT). Ethicon announced its agreement ...
... Jan. 20 IDEXX Laboratories, Inc. (Nasdaq: IDXX ), ... results for Friday, January 29 , at approximately 7:00 a.m. ... 9:00 a.m. (eastern) on that day. , Individuals can access ... IDEXX Web site, www.idexx.com . An archived edition of the call ...
Cached Medicine Technology:IDEXX Laboratories to Release 2009 Fourth Quarter and Full-Year Financial Results 2
... is a versatile solution designed to optimize ... from preparation to diagnosis and therapy, for ... Artis dTC, your cath lab becomes an ... leaves you free to concentrate on what ...
The AXIOM Artis TC is ideal for applications above and beyond standard cardioangiography, and features:, Single plane C-Arm, ceiling-mounted, Full-size CCD camera, ...
... Artis BC is a biplane ... architecture ideal for cardiological diagnostics ... ergonomic architecture enables you to ... to focus on:, Interventional ...
The ACUSON Sequoia C512 system elevates imaging and Doppler performance through new, high-density acoustic sampling, precise control of the transmitted acoustic waveform, and new transducer technolog...
Medicine Products: